Advanced Search
Contact | Corporate | Help

Phase I-II for Patients With Recurrent or Refractory NSCLC

Sponsors:
  • M.D. Anderson Cancer Center
  • Millennium Pharmaceuticals, Inc.
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Bortezomib
Enrollment:
42

Additional information about NCT00411593.


SourceSolution © 2008-2012